FDA approves Pfizer's Lorbrena treatment for certain lung cancer patients Medical Dialogues Bureau7 Nov 2018 4:10 AM GMTLorbrena, known chemically as lorlatinib, received an accelerated approval, Pfizer said. Its continued approval may depend on verification of clinical...